fda glp-1 compounding enforcement news october 2025 Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Report: FDA must enforce rules

Nasunin is the pigment concentrated in the purple peel and has demonstrated the abilityu to neutralize free radicals and bind excess iron in lab studies

GLP-3 A common point of confusion in early-stage research is the distinction between various glucagon-derived peptides

Theyre excited about their weight-loss progressbut frustrated that they now feel backed up, uncomfortable, or afraid to eat

GLP-1 Agonists as a Complementary Tool : In contrast, while GLP-1 agonists can aid in reducing body weight and improving health markers, they are less likely to produce the transformative weight loss that is often necessary for significant disease resolution in morbidly obese patients

He co-founded CHADD of New York and led the Institute for the Advancement of ADHD Coaching